Abstract: Thea Energy, Inc. is currently developing the “Eos” planar coil stellarator, the company’s first integrated fusion system capable of forming optimized stellarator magnetic fields without ...

US Food and Drug Administration (FDA) has accepted the company’s Type C meeting request and SKNJCT-003 Phase 2 study has randomized more than 75% of patients Philadelphia, Pennsylvania--(Newsfile Corp ...

To the maximum extent permitted by applicable law, vx-underground and/or affiliates who have submitted content to vx-underground, shall not be liable for any indirect, incidental, special, ...